Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of $10.90 billion. The enterprise value is $11.41 billion.

Market Cap	10.90B
Enterprise Value	11.41B

Important Dates

The next confirmed earnings date is Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Guardant Health has 131.17 million shares outstanding. The number of shares has increased by 2.14% in one year.

Current Share Class	131.17M
Shares Outstanding	131.17M
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	+3.08%
Owned by Insiders (%)	4.13%
Owned by Institutions (%)	100.73%
Float	125.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.10
Forward PS	8.33
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	11.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.84

Current Ratio	4.84
Quick Ratio	4.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-111.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-15.59%
Return on Invested Capital (ROIC)	-19.43%
Return on Capital Employed (ROCE)	-25.50%
Weighted Average Cost of Capital (WACC)	11.54%
Revenue Per Employee	$391,868
Profits Per Employee	-$166,112
Employee Count	2,506
Asset Turnover	0.56
Inventory Turnover	4.45

Taxes

Income Tax	-1.26M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +72.03% in the last 52 weeks. The beta is 1.65, so Guardant Health's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	+72.03%
50-Day Moving Average	90.44
200-Day Moving Average	83.01
Relative Strength Index (RSI)	41.49
Average Volume (20 Days)	2,200,339

Short Selling Information

The latest short interest is 11.64 million, so 8.88% of the outstanding shares have been sold short.

Short Interest	11.64M
Short Previous Month	13.70M
Short % of Shares Out	8.88%
Short % of Float	9.26%
Short Ratio (days to cover)	5.67

Income Statement

In the last 12 months, Guardant Health had revenue of $982.02 million and -$416.28 million in losses. Loss per share was -$3.32.

Revenue	982.02M
Gross Profit	633.01M
Operating Income	-436.30M
Pretax Income	-417.54M
Net Income	-416.28M
EBITDA	-396.56M
EBIT	-436.30M
Loss Per Share	-$3.32

Full Income Statement

Balance Sheet

The company has $1.20 billion in cash and $1.71 billion in debt, giving a net cash position of -$508.54 million or -$3.88 per share.

Cash & Cash Equivalents	1.20B
Total Debt	1.71B
Net Cash	-508.54M
Net Cash Per Share	-$3.88
Equity (Book Value)	-99.31M
Book Value Per Share	-0.76
Working Capital	1.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$184.76 million and capital expenditures -$48.31 million, giving a free cash flow of -$233.07 million.

Operating Cash Flow	-184.76M
Capital Expenditures	-48.31M
Depreciation & Amortization	39.74M
Net Borrowing	402.50M
Free Cash Flow	-233.07M
FCF Per Share	-$1.78

Full Cash Flow Statement

Margins

Gross margin is 64.46%, with operating and profit margins of -44.43% and -42.39%.

Gross Margin	64.46%
Operating Margin	-44.43%
Pretax Margin	-42.52%
Profit Margin	-42.39%
EBITDA Margin	-40.38%
EBIT Margin	-44.43%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.14%
Shareholder Yield	-2.14%
Earnings Yield	-3.82%
FCF Yield	-2.14%

Dividend Details

Analyst Forecast

The average price target for Guardant Health is $119.79, which is 44.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$119.79
Price Target Difference	44.17%
Analyst Consensus	Strong Buy
Analyst Count	19
Revenue Growth Forecast (5Y)	22.97%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of 0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	4